HCCC - Alpha Tau Medical going public via a SPAC merger at $1 billion valuation

Dzmitry Dzemidovich/iStock via Getty Images Alpha Tau Medical Limited is planning a listing on Nasdaq after the oncology therapeutics company entered into a business combination agreement with special purpose acquisition company Healthcare Capital Corp ([[HCCC]] +2.1%). The closing of the business combination expected by the end of this year will see Israel-based Alpha Tau getting listed on Nasdaq with $362M in cash in the balance sheet. The company will continue to be managed by its current leadership team, and Alpha Tau investors will retain the full ownership of their equity holdings in the public company. Dr. David M. Milch, chairman of Healthcare Capital Corp is expected to join the Alpha Tau board of directors. Alpha Tau is focused on the use of alpha radiation to treat solid tumors. Its proprietary Alpha DaRT has been granted the FDA’s Breakthrough Device Designation in the treatment of squamous cell carcinoma of the skin and oral

For further details see:

Alpha Tau Medical going public via a SPAC merger at $1 billion valuation